The following are ongoing Alzheimer’s Disease clinical trials in Canada:
Study to Evaluate Efficacy of ALZ-801 in APOE4/4 Early AD Subjects (APOLLOE4)
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer’s Disease (AD)
A Study of JNJ-63733657 in Participants With Early Alzheimer’s Disease (The AUTONOMY Study)
Study of ANAVEX2-73 for Treatment of Early Alzheimer’s Disease)